Yuta Maruki | Medicine and Health Sciences | Innovative Research Award

Published on by Research Scientist

Innovative Research Award

Yuta Maruki — National Cancer Center Hospital, Tokyo, Japan

Yuta Maruki
Affiliation National Cancer Center Hospital
Country Japan
Scopus ID 57204573534
Documents 67
Citations 452
h-index 11
Subject Area Medicine and Health Sciences
Event International Research Scientist Awards
ORCID 0000-0002-5045-8082

Yuta Maruki is a physician and clinical researcher at the National Cancer Center Hospital in Tokyo, Japan, whose documented work focuses on hepatobiliary and pancreatic oncology. His research and publications encompass biliary tract cancer, molecular oncology, endoscopic treatment, genomic profiling, procedural sedation, and clinically oriented cancer research. [1]

Abstract

Yuta Maruki is a physician and clinical researcher at the National Cancer Center Hospital in Tokyo, Japan, working in hepatobiliary and pancreatic oncology. His published research addresses biliary tract cancer, FGFR2 rearrangements, endoscopic management, pancreatic cancer genomic profiling, sedation during therapeutic endoscopy, and treatment strategies for hepatocellular carcinoma. His publication record includes prospective observational research, technical endoscopy studies, clinical investigations, and contemporary molecular oncology work. These areas connect translational cancer biology with practical diagnostic and therapeutic care, providing a documented scholarly profile relevant to an Innovative Research Award consideration within medicine and health sciences through multidisciplinary research and care delivery.

Keywords

Biliary tract cancer, cholangiocarcinoma, FGFR2 rearrangements, molecular oncology, genomic profiling, pancreatic cancer, endoscopic ultrasound, biliary drainage, malignant biliary strictures, propofol sedation, therapeutic endoscopy, hepatocellular carcinoma, pharmacological downstaging, precision oncology, biomarker analysis, clinical trials, translational cancer research, and hepatobiliary oncology. molecular diagnostics and precision therapeutic approaches

Introduction

Yuta Maruki’s research profile is situated within hepatobiliary and pancreatic oncology, where molecular characterization and interventional endoscopy intersect with clinical decision making. His studies examine relevant questions involving biliary tract malignancies, pancreatic cancer, and therapeutic procedures. The work reflects collaboration across oncology, pathology, genomics, gastroenterology, and clinical research in Japan. [2]

Research Profile

Yuta Maruki is identified by the National Cancer Center Hospital as an attending physician specializing in hepatobiliary and pancreatic disease, with involvement in clinical trials and research. His institutional profile also describes gastrointestinal endoscopic practice, including gastroscopy and endoscopic retrograde cholangiopancreatography. His documented publications span molecular oncology and therapeutic endoscopy. [2]

Research Contributions

Yuta Maruki’s publications address connected research themes. The PRELUDE study investigated FGFR2 rearrangements in advanced or recurrent biliary tract carcinoma, while later work examined molecular features of cholangiocarcinoma and treatment. Other studies address endoscopic drainage, genomic tissue acquisition, propofol sedation, and pharmacological downstaging, illustrating a broad research portfolio in oncology. [3]

Publications

Yuta Maruki has published on FGFR2 rearrangements in biliary tract carcinoma, endoscopic drainage of malignant biliary strictures, propofol sedation during biliary and pancreatic procedures, genomic profiling of unresectable pancreatic cancer, and pharmacological downstaging in hepatocellular carcinoma. Recent work also includes molecular classification and treatment experience involving FGFR-directed therapy in cholangiocarcinoma. [3] [4]

Research Impact

Yuta Maruki’s research impact can be described through the relevance and continuity of his publication themes than through unsupported claims. His studies contribute evidence concerning molecular testing, endoscopic techniques, genomic profiling, procedural safety, and treatment selection. Citation metrics supplied for this profile indicate 452 citations and an h-index of 11. [3]

Award Suitability

Yuta Maruki’s documented research record provides evidence-based areas for consideration in an Innovative Research Award context, including translational oncology, molecular characterization of biliary cancers, therapeutic endoscopy, and clinically oriented cancer research. His publications demonstrate sustained engagement with multidisciplinary questions connecting laboratory-informed biomarkers, diagnostic procedures, treatment strategies, and patient-focused clinical practice. [4]

Conclusion

Yuta Maruki’s profile combines specialist clinical practice with research in hepatobiliary and pancreatic oncology. His publications address molecular alterations, cancer diagnostics, endoscopic interventions, procedural safety, and therapeutic strategies. The available institutional and publication records provide a factual basis for describing his research trajectory and relevance to medicine and health sciences. [2]

References

  1. National Cancer Center Hospital. Yuta Maruki — Department of Hepatobiliary and Pancreatic Oncology.
    https://phase1-oncol.ncc.go.jp/en/members/yuta-maruki/
  2. Maruki, Y., Morizane, C., Arai, Y., et al. (2021). Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study). Journal of Gastroenterology.
    https://doi.org/10.1007/s00535-020-01735-2
  3. Maruki, Y., Hijioka, S., Yagi, S., et al. (2025). Sedative effects of propofol and risk factors for excessive sedation in the endoscopic treatment of biliary and pancreatic diseases. DEN Open, 5(1), e417.
    https://doi.org/10.1002/deo2.417
  4. Maruki, Y., Yatabe, Y., Mizoguchi, C., et al. (2026). FGFR2 Fusions or Rearrangements in Young Intrahepatic and Perihilar Cholangiocarcinoma Patients: Key Genetic Insights From a Pan-Asian Study. Hepatology Research.
    https://doi.org/10.1111/hepr.70031
  5. Maruki, Y., Morizane, C., et al. (2025). First Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma with Tasurgratinib Following Regulatory Approval: A Case Report from Clinical Practice. International Journal of Molecular Sciences.
    https://doi.org/10.3390/ijms26125586

Dr Abdullah alsaiari | Infection Prevention and Control | Best Researcher Award

Published on by Research Scientist

Dr Abdullah alsaiari | Infection Prevention and Control | Best Researcher Award

Main Author at King Salman Hospital, Ministry of Health, Saudi Arabia

Dr. Abdullah Khalid AlSaiari is a highly motivated Infection Prevention and Control Specialist based in Riyadh, Saudi Arabia. With extensive expertise in managing healthcare-associated infections (HAIs), training healthcare professionals, and ensuring workplace safety, Dr. AlSaiari is recognized for his leadership and dedication to fostering safe healthcare environments. His skills in epidemiological analysis and strategic planning enable effective policy compliance and multidisciplinary collaboration, ensuring high-quality patient care.

Publication Profile

orcid

🎓 Education

  • Master’s Degree in Infection Prevention and Control
    • Alfaisal University, Riyadh, Saudi Arabia | First Class Honors (Graduated: January 2022)
  • Diploma of Higher Education in Advanced Endodontics
    • Master Academy (Graduated: 2019)
  • Bachelor of Science in Dental Surgery
    • Najran University, Najran, Saudi Arabia (Graduated: 2014)

💼 Professional Experience

Senior of Infection Prevention and Control

King Salman Hospital, Riyadh | March 2021 – Present

  • Conducts training on HAIs prevention and presents annual infection control plans.
  • Analyzes infection data to identify trends and risk factors.
  • Leads outbreak investigations and audits for compliance with safety policies.

Head of Infection Prevention and Control

Saudi German Hospital, Riyadh | October 2020 – January 2021

  • Oversaw risk assessments, compliance audits, and staff training programs.
  • Collaborated with senior management to address infection prevention challenges.

Supervisor of Infection Control and Prevention

Quarantine Centers, Riyadh | March 2020 – October 2020

  • Managed compliance in quarantine centers and enhanced patient safety initiatives.

🔬 Contributions and Research Focus

Dr. AlSaiari’s contributions to the field extend beyond clinical practice into research and academia. His work emphasizes innovation in infection prevention, including the integration of bioengineering solutions into dental and clinical settings. His notable publication, “Bioengineering Innovations in Global Dental Infection Control: Applications and Adaptations in Clinical Settings“ (2024), reflects his forward-thinking approach and has been cited widely in infection control research.

Additionally, his literature review on gagging management showcases his dedication to improving patient comfort during dental procedures. These contributions underscore his dual focus on enhancing patient safety and advancing scientific knowledge.

🏅 Accolades and Recognition

Dr. AlSaiari’s efforts have been recognized at national and institutional levels. During the COVID-19 pandemic, his outstanding contributions earned him the Medal of Honor from the Ministry of Health. This prestigious accolade underscores his critical role in combating one of the most significant public health challenges of the century.

He has also been a prominent speaker, presenting at the 4th and 6th Dental Student Scientific Meetings (DSSM) in Qassim, where he shared insights into infection prevention strategies.

🌟 Impact and Influence

Dr. AlSaiari’s influence extends to public health education, where he has actively engaged in awareness campaigns, such as the Seasonal Influenza Vaccination Awareness Campaign at King Fahad Medical City. His efforts to organize health education days in Najran have empowered communities with knowledge about disease prevention.

Within healthcare institutions, his leadership has fostered safer environments, reducing infection risks and enhancing patient care quality. His ability to train and mentor healthcare professionals ensures that his expertise is effectively disseminated to future generations.

📜 Legacy and Future Contributions

As a thought leader in infection prevention, Dr. AlSaiari continues to innovate and inspire. His upcoming projects include the development of advanced infection control guidelines tailored to high-risk healthcare settings and further exploration of bioengineering applications in clinical practice.

Dr. AlSaiari’s legacy is one of resilience, innovation, and dedication. He exemplifies how a healthcare professional can transcend traditional roles to become a pioneer in infection prevention and public health. His work not only safeguards lives today but also sets a benchmark for future practices, ensuring lasting contributions to global health and safety.

Publication Top Notes

Infection Prevention and Control

  • Bioengineering Innovations in Global Dental Infection Control: Applications and Adaptations in Clinical Settings
    • Author: Dr. Abdullah Khalid AlSaiari
    • Year: 2024
    • Journal: International Dental Journal
    • DOI: 10.1016/j.identj.2024.12.011
    • Summary: This publication highlights advancements in bioengineering tailored for dental infection control, emphasizing innovative applications in clinical environments.
  • Gagging and its Management – A Review of the Literature
    • Author: Dr. Abdullah Khalid AlSaiari
    • Year: Not specified
    • Journal: Not specified
    • Summary: This review discusses various strategies for managing gagging reflexes in dental practice, providing a comprehensive analysis of existing literature.